Menopause Journal Highlights Three DOR Studies as Among Most Significant in Their History
The journal Menopause selected three DOR studies for its 25th commemorative issue highlighting the most important studies in the journal's history.
Delivering the Next Generation of Diabetes Scientists
The Kaiser Permanente Division of Research has received a T32 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to train young scientists in translating research into practice for people with type 2 diabetes and prediabetes.
Studying Life After Breast Cancer
When Sandra Domingue attends her regular fitness class at the Bayview Hunter’s Point YMCA in San Francisco, she’s not thinking about how her time at the gym, which includes both socializing and exercise, could help her live longer.
Flu Vaccine Prevents Flu-Related Hospitalizations in Pregnant Women
Kaiser Permanente collaborated with CDC researchers to study the effectiveness of flu vaccinations in preventing influenza-associated hospitalizations during pregnancy.
A Better Way to Assess Ovarian Cancer Risk
New radiology guidelines developed by Kaiser Permanente gynocological oncologist and researcher Betty Suh-Burgman, MD, allow women at higher risk for ovarian cancer to be promptly referred for surgical evaluation while women at low risk can safely avoid surgery.
5 Questions for…Candyce Kroenke
"As long as I can remember, my family was interested in how diet and lifestyle influenced health and longevity. It was like living life according to an epidemiological textbook!"
Women with Pregnancy-related Nausea and Vomiting Use Marijuana More
New Kaiser Permanente study adds evidence to body of research suggesting pregnant women are using marijuana to self-medicate morning sickness.
Researcher Spotlight: Susan Brown’s Deep Roots in Disease Prevention Research
Brown, a research scientist, reflects on her family’s unique connection to Kaiser Permanente and carrying forward her mother’s belief in the importance of disease prevention research.
“Catch-up” HPV Vaccination Works for Females up to Age 20 Years at First Dose, Not Older Ages
Kaiser Permanente study confirms recommendations for catch-up HPV vaccination with 3 doses in females aged 15 to 20, but not when started at or after age 21.
Obesity, High Blood Pressure and Glucose Intolerance Associated with Higher Risk of C-sections
Kaiser Permanente study provides detailed information on links between cardiometabolic conditions and cesarean sections.
